Cholesterol-Lowering Drug Fenofibrate Can Reduce The Risk of Corona Infection

Fenofibrate, a cholesterol-lowering drug, can reduce the risk of corona infection by up to 70 percent. Researchers from the University of Birmingham in the UK have made this claim in their recent research. Researchers claim the fenofibric acid present in this drug reduces the infection of Covid. This has also been proved in early clinical trials.

What is fenofibrate

Fenofibrate is an oral drug. It is used to control cholesterol and lipids in the blood. This medicine is easily available all over the world and is also cheap. Most drug authorities around the world have also approved the use of the drug on patients with cholesterol.

5 big things of research

• Prevents the condition from becoming critical: Researcher Eliza Vicenzi says, research results show that fenofibrate has the ability to prevent corona infection from becoming serious. It also helps prevent the virus from spreading.
• The vaccine can be an alternative: Researchers say, after the completion of all clinical trials, this drug can also be given to those who cannot be given the vaccine. For example, children and patients suffering from hyperimmune disorders.
• An experiment was done on the original strain of Corona: Scientists observed the effect of the drug Fenofibrate on cells infected with the original strain of Corona in the lab last year. The result was found to reduce the risk of infection by 70 percent.
• The drug is also effective on the alpha-beta stain: This drug is being tested on corona patients admitted to hospitals in America and Israel. Scientists say this drug is also effective on alpha, beta strains of the corona.
• Investigating the effect on Delta strain: Researchers say, the Delta strain of Corona is extremely dangerous. Research is being done on how effective the drug Fenofibrate is on this strain. Results will be released soon.

Read More: PM Modi to hold meetings with Council of Ministers next week, likely to discuss Centre's vision for India

Like and Follow us on :

Twitter          Facebook         Instagram          YouTube